LSTA: Lisata Therapeutics, Inc. Stock

by  •  • Comments Off on LSTA: Lisata Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 21.66
Enterprise Value ($M) 1.90
Book Value ($M) 33.44
Book Value / Share 3.98
Price / Book 0.65
NCAV ($M) 32.93
NCAV / Share 3.92
Price / NCAV 0.66

Profitability (mra)
Return on Invested Capital (ROIC) -0.62
Return on Assets (ROA) -0.38
Return on Equity (ROE) -0.43

Liquidity (mrq)
Quick Ratio 8.03
Current Ratio 8.03

Balance Sheet (mrq) ($M)
Current Assets 37.69
Assets 38.20
Liabilities 4.76
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic And Diluted Since Acquisition n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 8,296 36,793 22.55
2025-02-03 32,349 78,967 40.97
2025-01-31 509 5,446 9.35
2025-01-30 1,805 21,226 8.50

(click for more detail)

Similar Companies
LPCN – Lipocine Inc. LPTX – Leap Therapeutics, Inc.
LQDA – Liquidia Corporation LTRN – Lantern Pharma Inc.
MBIO – Mustang Bio, Inc.


Financial data and stock pages provided by
Fintel.io